文献速递核素与放射性配体治疗

68Ga-Pentixafor PET/CT评估原发性醛固酮增多症患者超选择性肾上腺动脉栓塞术后的治疗结局

68Ga-Pentixafor PET/CT for the assessment of therapeutic outcomes following superselective adrenal arterial embolization in patients with primary aldosteronism.
PubMed 文献 · EJNMMI Res · 2025-01-16

本研究纳入27例原发性醛固酮增多症患者,在超选择性肾上腺动脉栓塞术(SAAE)后行68Ga-Pentixafor PET/CT,评估其疗效评价价值。临床转归方面2例完全缓解、25例部分缓解;生化转归方面13例完全缓解、13例部分缓解、1例未缓解。ΔTLR-40 min在不同生化转归间差异有统计学意义(P=0.041),ΔTLR-40 min≥0.07者转归更好(AUC=0.789,P=0.041)。

要点

  • 27例患者SAAE后临床转归为2例完全缓解、25例部分缓解。
  • 生化转归为13例完全缓解、13例部分缓解、1例未缓解。
  • ΔTLR-40 min≥0.07者生化转归更好(AUC=0.789,P=0.041)。

核心结论

  • 68Ga-Pentixafor PET/CT可及时评估原发性醛固酮增多症患者SAAE后的治疗结局,从而改善临床决策与患者管理。

研究设计与样本

  • 本研究旨在用68Ga-Pentixafor PET/CT评估原发性醛固酮增多症患者SAAE的疗效,以建立SAAE治疗后患者的影像学评价方法;共纳入27例患者。

主要发现

  • 27例患者中,2例临床完全缓解,25例部分缓解。
  • 生化方面,13例完全缓解,13例部分缓解,1例未缓解。
  • 对于醛固酮 producing 腺瘤患者,PET/CT视觉分析与半定量分析均可有效评估病灶放射性摄取的变化。
  • 对于特发性醛固酮增多症患者,PET/CT参数在评估SAAE疗效方面比视觉分析更有效。
  • ΔTLR-40 min在不同生化转归间差异有统计学意义(P=0.041),ΔTLR-40 min≥0.07的患者转归更好(AUC=0.789,P=0.041)。

关键数值与推荐

  • ΔTLR-40 min在不同生化转归间差异有统计学意义(P=0.041)。
  • ΔTLR-40 min≥0.07的患者转归更好(AUC=0.789,P=0.041)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Superselective adrenal artery embolization (SAAE) represents a novel therapeutic strategy for managing primary aldosteronism (PA). Currently, the evaluation of its efficacy is primarily restricted to clinical indicators, with a notable deficiency in imaging evaluation methodologies. In recent years, several studies have investigated the application of 68Ga-Pentixafor PET/CT for the classification of PA. However, there is a scarcity of specific research investigating the role of PET/CT in the evaluation of efficacy of this condition. Consequently, this study aims to evaluate the therapeutic efficacy of SAAE in patients with PA using 68Ga-Pentixafor PET/CT, with the objective of establishing imaging evaluation methodologies for assessing PA patients post-SAAE treatment. RESULTS: Of the 27 patients, 2 achieved complete clinical remission, while 25 experienced partial remission. Biochemically, 13 patients attained complete remission, 13 had partial remission, and 1 did not. For patients with aldosterone-producing adenoma, both visual and semi-quantitative analyses of PET/CT effectively assessed changes in radioactive uptake of the lesion. For idiopathic hyperaldosteronism patients, PET/CT parameters were more effective than visual analysis in evaluating SAAE efficacy. A significant difference in the ΔTLR-40 min parameter was observed across biochemical outcomes (P = 0.041), with patients having ΔTLR-40 min ≥ 0.07 showing better outcomes (AUC = 0.789, P = 0.041). CONCLUSIONS: 68Ga-Pentixafor PET/CT enables timely assessment of therapeutic outcomes in patients with PA following SAAE, thereby improving clinical decision-making and patient management.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Li M, Guan L, Yang L, et al. 68Ga-Pentixafor PET/CT for the assessment of therapeutic outcomes following superselective adrenal arterial embolization in patients with primary aldosteronism. EJNMMI Res. 2025. PMID: 39821475. doi:10.1186/s13550-024-01194-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。